- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen Aerogels") today announced that it will present at the Canaccord Genuity 34th Annual Growth Conference being held at the InterContinental Hotel, Boston, MA. The presentation will take place on Thursday, August 14, 2014 at 8:00 am Eastern Time. Presenting for management will be Donald R. Young, President & CEO of Aspen Aerogels. A live audio webcast and a replay of the company's presentation will be available on the Investors section of the Aspen Aerogels website at www.aerogel.com and also at the conference webcast link, wsw.com/webcast/canaccord14/aspn.
Additionally, Aspen Aerogels has posted the presentation slides to be used at this conference, titled "Investor Presentation", to the Investors section of its website, www.aerogel.com.
About Aspen Aerogels, Inc.
Aspen Aerogels is an energy technology company that designs, develops and manufactures innovative, high-performance aerogel insulation used primarily in large-scale energy infrastructure facilities. Headquartered in Northborough, Mass., Aspen Aerogels manufactures its Cryogel®, Pyrogel® and Spaceloft® products at its facility in East Providence, R.I.
Special Note Regarding Forward-Looking and Cautionary Statements
This press release or information it references may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements, including statements relating to Aspen Aerogels' future financial and operational performance. These statements are not historical facts but rather are based on Aspen Aerogels' current expectations, estimates and projections regarding Aspen Aerogels' business, operations and other factors relating thereto, including with respect to Aspen Aerogels' future financial and operational performance. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates," "outlook," and similar expressions are used to identify these forward-looking statements. Such forward-looking statements may include statements regarding, among other things, Aspen Aerogels' expectations about revenue, expenses, Adjusted EBITDA and GAAP EPS; beliefs about the continuing increased use of Aspen Aerogels' products by certain energy companies; and expectations about when Aspen Aerogels' third manufacturing line will become operational. All such forward-looking statements are based on management's present expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the following: any disruption in either of our two production lines or the manufacturing facility in which they are located; any failure to achieve an increase in production capacity that Aspen Aerogels' growth requires in a timely manner; any failure of demand for Aspen Aerogels' products; the failure to obtain significant additional capital to pursue Aspen Aerogels' growth strategy beyond construction of Aspen Aerogels' third production line; the failure of our products to become widely adopted; the competition Aspen Aerogels faces in its business; the failure to manage Aspen Aerogels' growth, and the demands that growth places on Aspen Aerogels' management systems and infrastructure; the general economic conditions and cyclical demands in the markets that Aspen Aerogels serves; any sustained downturn in the energy industry; the economic, operational and political risks associated with sales and expansion of operations in foreign countries; the loss of any direct customer, including contractors and OEMs; compliance with health and safety laws and regulations; shortages of raw materials; the maintenance and development of distribution channels; and the other risk factors discussed under the heading "Risk Factors" contained in our Quarterly Report on Form 10-Q for the three months ended June 30, 2014 filed with the Securities and Exchange Commission ("SEC") on August 8, 2014, as well as any updates to those risk factors filed from time to time in our periodic and current reports filed with the SEC. All statements contained in this press release are made only as of the date of this press release, and Aspen Aerogels does not intend to update this information unless required by law.
For more information, please click here
Copyright © Aspen Aerogels, Inc.If you have a comment, please Contact us.
|Related News Press|
News and information
New class of 3D-printed aerogels improve energy storage April 22nd, 2015
Aspen Aerogels, Inc. to Present at the Needham Growth Conference January 8th, 2015
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Graphenea embarks on a new era April 16th, 2015
Richards-Kortum elected to American Academy of Arts and Sciences: April 22nd, 2015